TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The Prepare for Kidney Care trial found no advantage in combined survival and quality-of-life outcomes for preparing for dialysis over structured conservative kidney management among older adults with kidney failure and frailty or other health conditions. Only 28% of participants assigned to prepare for dialysis started it. The results support offering both approaches for discussion, but do not apply to younger, fitter patients or people already on dialysis.
A randomized U.K. trial found that preparing for dialysis did not produce better combined outcomes for survival and quality of life than structured kidney care without dialysis among older people with kidney failure who also had frailty or other health conditions. The findings challenge dialysis as an automatic next step for this group, while supporting individualized decisions rather than a single default.
The Prepare for Kidney Care trial enrolled 445 people at 31 U.K. kidney centers, roughly half of the country’s kidney services. About 75% were aged 80 or older; the remainder were 65 to 79 and had additional health problems. Participants were randomly assigned to prepare for dialysis or to prepare for responsive management, a form of conservative kidney care that does not include dialysis, and were followed over time.
During an average follow-up of 4.5 years, neither approach led to better outcomes when length and quality of life were considered together, according to the report. Among participants preparing for dialysis, 28% went on to start treatment. In both groups, participants were more likely to die from other causes than to reach the point of requiring dialysis, reflecting the competing health risks in this population. The study took nine years to complete, including seven years of recruitment.
The trial did not compare dialysis with no care. Conservative kidney management is active treatment, and the report says people can change their pathway. Participants could withdraw from the study at any time. The findings are limited to older people with kidney failure and significant health needs; they do not apply to people already receiving dialysis or to younger, fitter patients, for whom dialysis and transplantation remain standard care.
A Choice Beyond Automatic Dialysis
The results offer patients, families and clinicians evidence for discussing more than one care pathway when kidney failure develops alongside frailty or multiple conditions. The similar combined outcomes do not mean the approaches are identical: treatment burdens, daily routines and individual priorities may differ. The study’s message is that dialysis should not be assumed to be the right choice for every older person in this group.
The findings may also inform NHS policy and clinical practice, but they do not prescribe a single choice for individual patients. Kidney Care UK policy director Fiona Loud said staff need support to help patients weigh options, and that care should be available wherever a person lives. The report says the trial was designed to strengthen evidence for shared decisions; it does not establish that either approach is preferable for every patient.
Products Worth Considering
Levoit Core 400S-P Smart Air Purifier for Large Rooms
Levoit Eleva 500X HEPA Air Purifier for Large Rooms
Fitbit Sense 2 Health and Fitness Smartwatch, Shadow Grey/Graphite
As an affiliate, we earn on qualifying purchases.
How the Trial Compared Care
Before this study, the report says, evidence directly comparing dialysis planning with conservative kidney management for older, frail people was limited. The Prepare for Kidney Care trial was led by the University of Bristol with Bristol NHS Foundation Trust. Its stated purpose was to provide evidence for patients and families making treatment decisions and to inform care policy.
Professor Fergus Caskey, the project lead and a renal medicine professor at Bristol, described conservative kidney management as an option that is increasingly recognized but has lacked direct comparative evidence. The randomized design assigned participants to prepare for one of two approaches, but it did not force them to follow that pathway: participants retained the choice to withdraw or change course. The report says the study’s results concern overall length and quality of life considered together, not a claim that the approaches have identical effects on every outcome or for every person.
“Both have pros and cons. They result in similar overall length and quality of life. Neither should be the default.”
— Fergus Caskey, University of Bristol project lead
Limits of the Evidence
The report gives the overall comparison for survival and quality of life together, but the supplied material does not provide detailed outcome measures, subgroup results, or estimates of uncertainty. It therefore does not show from these figures how outcomes differed for particular patients or which option may better match a given person’s priorities.
The findings also cannot be extended to younger, fitter patients or people already receiving dialysis. The report does not state how the results will change NHS guidance, how care access varies across regions, or what specific supports would be needed to make both pathways available consistently. Those questions remain open.
Applying Results in Kidney Services
The study is intended to inform discussions between patients, families and kidney-care teams, as well as policy deliberations. The next step is for clinicians and health services to consider how to present both pathways clearly and support patients in making choices that reflect their health circumstances and priorities. No specific NHS policy change or implementation timetable is reported in the source material.
For individuals, the report’s findings do not replace a clinical conversation: decisions depend on personal health and preferences, and the trial allowed participants to change their treatment pathway. Further reporting or guidance would be needed to clarify whether services will change and how the trial’s results translate into care across the U.K.
Key Questions
What did the Prepare for Kidney Care trial find?
It found no advantage for preparing for dialysis over structured conservative kidney management when overall survival and quality of life were considered together among the older participants with kidney failure and complex health needs.
Does conservative kidney management mean no treatment?
No. The report describes it as active kidney care that does not include dialysis. It also says patients can change their minds and move to dialysis if they choose.
How many participants in the dialysis-planning group started dialysis?
Twenty-eight percent of participants preparing for dialysis went on to start treatment during the study, according to the report.
Do the findings apply to everyone with kidney failure?
No. They apply to the older, frailer population studied. The report says the results do not apply to people already receiving dialysis or to younger and fitter patients, for whom dialysis and transplantation remain standard care.
Source: medicalxpress.com
